Viewing nowPioglitazone Tablets (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

MFDS item code 200708368 · Approved 2007.07.20 · Insurance code 698500500
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with Type 2 diabetes. It can be used alone as monotherapy or in combination with other oral hypoglycemic agents or insulin when sulfonylureas, metformin, or insulin are ineffective. Additionally, when using this medication, dietary control and exercise therapy must be followed, and nutritional counseling and weight loss may be recommended as needed. These various efforts are crucial for enhancing and maintaining the effectiveness of drug therapy. Therefore, this medication is used as part of comprehensive diabetes management to improve blood sugar control.
This medication is administered orally once daily, with or without food. 1. Monotherapy This medication may be started at 15 mg once daily as monotherapy in patients whose blood glucose is not adequately controlled with diet and exercise. If the effect is insufficient, the dose may be increased to 30 mg once daily. 2. Combination therapy - When used in combination with a sulfonylurea, administer an initial dose of 15 mg once daily; adjust the sulfonylurea dose if needed. - When used in combination with metformin, administer an initial dose of 15 mg once daily; adjustment of the metformin dose is generally not required. - When used in combination with insulin, administer 15 mg once daily; if hypoglycemia occurs, the insulin dose may be reduced by 10~25%. The maximum recommended dose should not exceed 30 mg once daily.
Use is not recommended in children younger than 18 years because there is no experience with use in this age group.
This medication is used for the treatment of diabetes and is effective in lowering blood sugar levels only in the presence of insulin. It may affect heart function, and should not be used in patients with heart failure or a history of heart failure. Patients should be closely monitored for symptoms of heart failure such as rapid weight gain, shortness of breath, and edema during treatment, and should consult a doctor immediately if these symptoms occur. This medication can cause fluid retention, which may worsen edema or heart failure, so it should be used cautiously in patients with edema or a high risk of heart disease. This medication is contraindicated in patients with a history of bladder cancer or those with active bladder cancer. Patients with poor liver function or severe renal impairment should not use this medication. Women who are pregnant or may become pregnant should avoid this medication, and premenopausal women require appropriate contraception due to the increased risk of pregnancy that may occur from ovulation stimulation. Regular liver function tests and blood sugar checks are required while taking this medication, and immediate medical evaluation is necessary if any abnormal symptoms arise. Additionally, when used with insulin or other hypoglycemic agents, there is a risk of hypoglycemia, so caution is needed, and adjustment of the doses of concomitant medications may be necessary. In case of overdose, even if there are no special symptoms, inform a medical professional immediately and seek appropriate treatment. The safety and effectiveness of this medication have not been confirmed in children, and it should be used cautiously in the elderly. Store this medication out of the reach of children, and keep it in its original container.
Congestive heart failure, excessive and rapid weight change, shortness of breath, edema, fluid retention, inadequate blood sugar control, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, abdominal distension, weight gain, hypoglycemia, urinary tract infection, back pain, dizziness, diarrhea, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular predisposition, worsening of congestive heart failure, emergency room visits due to congestive heart failure, adverse reactions related to edema, liver failure, diabetic macular edema accompanied by vision decrease, elevated serum ALT levels, decreased hemoglobin, decreased hematocrit, elevated serum creatine kinase, bladder cancer, dizziness, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, shortness of breath, itching, chest discomfort, trembling, chills, gastrointestinal disease, abdominal pain, epigastric discomfort, numbness, muscle rigidity, head discomfort, increased liver enzymes, worsening of liver disease, hives, eczema, arthralgia, knee abnormalities, arm weakness, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, heart function loss, fracture
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that is protected from light and air, and should be kept in a dry place. To maintain its effectiveness, it is best to store it at a temperature between 15 to 30 degrees Celsius, particularly around 25 degrees Celsius.
White round tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.